Absci (ABSI) Change in Accured Expenses (2020 - 2025)
Absci's (ABSI) quarterly Change in Accured Expenses came in at $2.5 million in Q3 2025, up 80.22% year-on-year from $1.4 million in Q3 2024, and up 22.87% quarter-over-quarter from $2.0 million in Q2 2025.
Absci (ABSI) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Absci has disclosed Change in Accured Expenses across 6 years of filings, most recently posting $2.5 million for Q3 2025.
- Change in Accured Expenses for Q3 2025 came in at $2.5 million, up 80.22% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.9 million (up 233.87% YoY), and the FY2024 annual result was -$295000.0, up 75.68% from the prior year.
- Change in Accured Expenses came in at $2.5 million for Q3 2025 at Absci, up from $2.0 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $3.9 million in Q3 2022 to a low of -$4.5 million in Q1 2022.
- The 5-year median for Change in Accured Expenses is -$374000.0 (2023), against an average of -$77947.4.
- Across the five-year window, Change in Accured Expenses slumped 1337.23% in 2021 and soared 437.49% in 2022, its largest moves.
- Absci's Change in Accured Expenses stood at $2.1 million in 2021, then slumped by 123.28% to -$500000.0 in 2022, then climbed by 25.2% to -$374000.0 in 2023, then jumped by 303.21% to $760000.0 in 2024, then surged by 230.79% to $2.5 million in 2025.
- The last three Change in Accured Expenses figures came in at $2.5 million (Q3 2025), $2.0 million (Q2 2025), and -$3.4 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Dec 31, 2024 | 760,000.00 |
| Dec 31, 2024 | 760,000.00 |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | -3.91 Mn |
| Mar 31, 2024 | -3.91 Mn |
| Dec 31, 2023 | -374,000.00 |
| Dec 31, 2023 | -374,000.00 |
| Sep 30, 2023 | 2.96 Mn |
| Sep 30, 2023 | 2.96 Mn |
| Jun 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -1.38 Mn |